ArticleMethods in molecular biology (Clifton, N.J.)2025
Metabolite Analog-Induced Proteome Changes.
Article in Methods in molecular biology (Clifton, N.J.), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Metabolites are small molecules crucial for metabolic processes, while their analogs are structurally similar compounds used to study and manipulate these pathways in medicine and science. Metabolite analogs serve as powerful tools in drug development, research, and therapeutics by mimicking or inhibiting natural metabolites to alter biochemical pathways, impacting both catabolism and anabolism. These analogs are pivotal in research and treatment, influencing pathways like catabolism and anabolism. Common metabolites like glucose, amino acids, and nucleotides play vital roles in pathways such as PTEN and mTOR, which are essential for regulating cell growth, proliferation, and survival. By influencing these pathways, metabolite analogs can help elucidate metabolic mechanisms and offer potential treatments for diseases like cancer and metabolic disorders. This protocol chapter will detail the preparation and handling of metabolites, specifically focusing on a PTEN inhibitor. We will outline the steps for dissolving and storing these compounds, followed by a comprehensive protein extraction protocol. Finally, the use of Proteome Discoverer software will be discussed to analyze the resultant proteome changes.
Indexed as
Identifiers
40498186What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.